History
  • No items yet
midpage
617 F. App'x 208
3rd Cir.
2015
Read the full case

Background

  • Dhillon appeals a district court order denying his claim to a share of Endo’s FCA settlement, affirming Peggy Ryan as the sole Relator eligible for the award.
  • The government intervened for settlement purposes on February 21, 2014, and Endo agreed to pay $171.9 million to resolve the off-label use allegations of three Relators.
  • Ryan filed the earliest Amended Complaint (March 31, 2009) and Dhillon’s later action followed; the district court held Ryan first-to-file, barring Dhillon from the Relator’s share.
  • The district court also held Ryan’s claim was not barred by public disclosure absent an “original source” showing by Dhillon and ruled on Rule 9(b) sufficiency under Foglia.
  • Dhillon appealed the June 23, 2014 order, while also pursuing motions for reconsideration and other ancillary relief; this court granted summary affirmance.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
First-to-file applies to bar Dhillon Dhillon first to state plausible claim despite Ryan’s 2009 filing Ryan’s Amended Complaint was first-filed and adequately pled Dhillon barred; Ryan first-to-file relator entitled to share
Original source requirement governs Dhillon’s relief Dhillon is an original source; public disclosures do not bar him Dhillon failed to show independent knowledge; not original source Dhillon not original source; Ryan eligible for Relator’s share
Rule 9(b) pleading standard under Foglia governs Ryan’s Amended Complaint Ryan’s Amended Complaint details a false-claims scheme with reliable indicia Foglia applies and shows plausible claims Ryan’s Amended Complaint satisfies Rule 9(b) under Foglia; plausible relief
Public disclosure bar supports dismissal for lack of jurisdiction Public disclosures alone do not defeat relator status if original source present Public disclosures predated complaints; bar applies unless original source Public disclosures present; Dhillon not established as original source; dismissal proper

Key Cases Cited

  • LaCorte v. SmithKline Beecham Clinical Labs., Inc., 149 F.3d 227 (3d Cir. 1998) (first-to-file and original-source framework in FCA)
  • Foglia v. Renal Ventures Management, LLC, 754 F.3d 153 (3d Cir. 2014) (rule for pleading FCA claims under Rule 9(b))
  • U.S. ex rel. Shea v. Cellco Partnership, 748 F.3d 338 (D.C. Cir. 2014) (second action vs. first action; applies to FCA pleading)
  • Rille v. PricewaterhouseCoopers LLP, 748 F.3d 818 (8th Cir. 2014) (recovery/finder’s fee where relators are original sources)
  • U.S. ex rel. Wilkins v. United Health Group, Inc., 659 F.3d 295 (3d Cir. 2011) (original-source/relator framework in FCA)
Read the full case

Case Details

Case Name: United States Ex Rel. Dhillon v. Endo Pharmaceuticals
Court Name: Court of Appeals for the Third Circuit
Date Published: Jun 11, 2015
Citations: 617 F. App'x 208; 14-3377
Docket Number: 14-3377
Court Abbreviation: 3rd Cir.
Log In